OMI Owens & Minor
- 17.370
- +0.080+0.46%
- 17.370
- 0.0000.00%
Owens & Minor News
Owens & Minor to Present at the Leerink Partners' Healthcare Crossroads Conference on May 29, 2024
Owens & Minor, Inc. (NYSE:OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and
Express News | NYSE Order Imbalance 50245.0 Shares on Buy Side
Here's How Much $1000 Invested In Owens & Minor 5 Years Ago Would Be Worth Today
Owens & Minor (NYSE:OMI) has outperformed the market over the past 5 years by 25.23% on an annualized basis producing an average annual return of 38.3%. Currently, Owens & Minor has a market capitaliz
Research Alert: CFRA Drops Analytical Coverage On Shares Of Owens & Minor, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are dropping analytical coverage on s
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024
Owens & Minor, Inc. (NYSE:OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and
Owens & Minor Shareholders Endorse Key Proposals and Directors
Owens & Minor Elevates Sarkar to Executive VP & CIO
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Owens & Minor (OMI) and Illumina (ILMN)
$1000 Invested In Owens & Minor 5 Years Ago Would Be Worth This Much Today
Owens & Minor (NYSE:OMI) has outperformed the market over the past 5 years by 23.92% on an annualized basis producing an average annual return of 36.22%. Currently, Owens & Minor has a market capitali
Owens & Minor Is Maintained at Neutral by Baird
Owens & Minor Is Maintained at Neutral by Baird
Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $24
Baird analyst Eric Coldwell maintains Owens & Minor (NYSE:OMI) with a Neutral and lowers the price target from $28 to $24.
Owens & Minor Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 31.72% Baird $28 → $24 Maintains Neutral 04/30/2024 53.68% Citigroup $24 → $28 Maintains Neutra
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Idexx Laboratories (IDXX) and CytomX Therapeutics (CTMX)
Investor Optimism Improves Slightly Following Jobs Data; Dow Jumps 450 Points
The CNN Money Fear and Greed index showed slight improvement in the overall market sentiment, while the index remained in the "Fear" zone on Friday.U.S. stocks settled higher on Friday, with the Dow J
Owens & Minor Treads Carefully: Navigating Legal Risks in Unregistered Equity Transactions
Benign Growth For Owens & Minor, Inc. (NYSE:OMI) Underpins Stock's 34% Plummet
Owens & Minor, Inc. (NYSE:OMI) shares have had a horrible month, losing 34% after a relatively good period beforehand. The recent drop has obliterated the annual return, with the share price now do
Owens & Minor First Quarter 2024 Earnings: EPS Misses Expectations
Owens & Minor Inc (OMI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Earnings Call Summary | Owens & Minor(OMI.US) Q1 2024 Earnings Conference
The following is a summary of the Owens & Minor, Inc. (OMI) Q1 2024 Earnings Call Transcript:Financial Performance:Owens & Minor reported Q1 2024 revenue of $2.6 billion, up 4% compared to the prior y
Owens & Minor(OMI.US) Officer Sells US$585.68K in Common Stock
$Owens & Minor(OMI.US)$ Officer Bernocchi Perry A sold 24,094 shares of common stock on May 1, 2024 at an average price of $24.3081 for a total value of $585.68K.Source: Announcement What is statement
Analysis
Price Target
No Data
